Table.
No. of Patients | SBP, mm Hg | DBP, mm Hg | PP, mm Hg | DDD, Total Per Day | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Warfarin | Control | Warfarin | Control | Warfarin | Control | Warfarin | Control | Warfarin | Control | |
Baseline | 58 | 58 | 136±17 | 145±19* | 77±10 | 77±11 | 59±13 | 67±16 | 3.2±2.5 | 1.8±1.6† |
12 months | 56 | 57 | 136±14 | 141±15* | 75±10 | 77±10 | 61±13 | 64±12 | 4.2±2.7 | 2.4±2.1† |
24 months | 54 | 57 | 131±15 | 139±16† | 74±10 | 76±10 | 57±14 | 63±16 | 4±2.4 | 2.6±2.1† |
36 months | 48 | 57 | 128±14 | 141±15† | 71±9 | 76±9 | 56±12 | 65±13 | 4.3±2.7 | 2.8±2.1† |
Data are presented as mean ± SD. *P<.05 vs warfarin. †P<.01 vs warfarin. DDD indicates defined daily doses of antihypertensive agents according to the World Health Organization Collaborating Centre for Drug Statistics Methodology; SBP, systolic blood pressure; DBP, diastolic blood pressure; and PP, pulse pressure. |